When primary hyperparathyroidism comes as good news
Daniela Gallo(University of Insubria), Eliana Piantanida(University of Insubria), Giuseppe Perrucchini(Istituto Ortopedico Galeazzi), Linda Gentile(University of Insubria), Antonina Parafioriti(Istituto Ortopedico Gaetano Pini), Maria Laura Tanda(University of Insubria), Luigi Bartalena(Indiana University School of Medicine), Graziella Pinotti(Medica (Italy)), Ilaria Marcon(Ospedale di Circolo e Fondazione Macchi), Bohdan Patera(University of Insubria), Sara Rosetti(University of Insubria), Elisabetta Armiraglio(Istituto Ortopedico Gaetano Pini)
Cited by 6
Related Papers
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy
|European Journal of Endocrinology|2021|948
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy
|European Thyroid Journal|2016|946
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684